tiprankstipranks
Mayne Pharma Group (AU:MYX)
ASX:MYX

Mayne Pharma Group (MYX) Technical Analysis

6 Followers

Summary of all the Indicators

Overall Consensus
Neutral
8Bullish
6Neutral
8Bearish
Technical Analysis Consensus
Neutral
2Bullish
6Neutral
2Bearish
Moving Average Consensus
Neutral
6Bullish
0Neutral
6Bearish
Mayne Pharma Group’s (MYX) Moving Averages Convergence Divergence (MACD) indicator is -0.04, suggesting Mayne Pharma Group is a Sell.
Mayne Pharma Group’s (MYX) 20-Day exponential moving average is 5.36, while Mayne Pharma Group’s (MYX) share price is AU$5.24, making it a Sell.
Mayne Pharma Group’s (MYX) 50-Day exponential moving average is 5.32, while Mayne Pharma Group’s (MYX) share price is AU$5.24, making it a Sell.

Mayne Pharma Group (MYX) Pivot Points

Feb 27, 2024, 02:00 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
5.04
5.13
5.18
5.27
5.32
5.41
5.46
Fibonacci
5.13
5.18
5.22
5.27
5.32
5.36
5.41
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Mayne Pharma Group (MYX) Moving Averages

Feb 27, 2024, 02:00 AM
Period
Simple
Exponential
MA5
5.31Buy
5.31Buy
MA10
5.35Sell
5.33Sell
MA20
5.34Sell
5.36Sell
MA50
5.60Sell
5.32Sell
MA100
4.84Buy
5.04Buy
MA200
4.47Buy
4.65Buy
Mayne Pharma Group’s (MYX) 10-Day exponential moving average is 5.33, while Mayne Pharma Group’s (MYX) share price is AU$5.24, making it a Sell.
Mayne Pharma Group’s (MYX) 100-Day exponential moving average is 5.04, while Mayne Pharma Group’s (MYX) share price is AU$5.24, making it a Buy.
Mayne Pharma Group’s (MYX) stock price is AU$5.24 and Mayne Pharma Group’s (MYX) 50-day simple moving average is 5.60, creating a Sell signal.
Mayne Pharma Group’s (MYX) stock price is AU$5.24 and Mayne Pharma Group’s (MYX) 100-day simple moving average is 4.84, creating a Buy signal.
Mayne Pharma Group’s (MYX) stock price is AU$5.24 and Mayne Pharma Group’s (MYX) 200-day simple moving average is 4.47, creating a Buy signal.

Mayne Pharma Group (MYX) Technical Indicators

Feb 27, 2024, 02:00 AM
Name
Value
Implied Action
RSI (14)
47.23
Neutral
STOCH (9,6)
46.04
Neutral
STOCHRSI (14)
40.00
Neutral
MACD (12,26)
-0.04
Sell
ADX (14)
20.41
Neutral
Williams %R
-53.85
Buy
CCI (14)
-64.25
Neutral
ATR (14)
0.19
-
Ultimate Oscillator
52.47
Neutral
ROC
0.57
Buy
Mayne Pharma Group’s (MYX) Relative Strength Index (RSI) is 47.23, creating a Neutral signal.
Mayne Pharma Group’s (MYX) Trend Strength Indicator (ADX) is 20.41, creating a Neutral signal.
Mayne Pharma Group’s (MYX) Commodity Channel Index (CCI) is -64.25, creating a Neutral signal.
Mayne Pharma Group’s (MYX) Price Rate of Change (ROC) is 0.57, creating a Buy signal.

FAQ

Is MYX a Buy, Hold, or Sell?
Based on MYX’s technical indicators, MYX is a Hold.
    What is MYX’s RSI (14)?
    MYX’s RSI (14) is 47.23, which suggests MYX is a Neutral.
      What is MYX’s MACD?
      MYX’s MACD is -0.04, which suggests MYX is a Sell.
        What is MYX’s 5-day moving average?
        MYX’s 5-day moving average is 5.31, which suggests MYX is a Buy.
          What is MYX’s 20-day moving average?
          MYX 20-day moving average is 5.34, which suggests MYX is a Sell.
            What is MYX’s 50-day moving average?
            MYX’s 50-day moving average is 5.60, which suggests MYX is a Sell.
              What is MYX’s 200-day moving average?
              MYX’s 200-day moving average is 4.47, which suggests MYX is a Buy.
                What is MYX’s Williams % R (14)?
                MYX’s Williams % R (14) is -53.85, which suggests MYX is a Buy.
                  What is MYX’s CCI (14)?
                  MYX’s CCI (14) is -64.25, which suggests MYX is a Neutral.
                    What is the share price of Mayne Pharma Group?
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis